Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer

Warren D. Foltz, Andy Wu, Peter Chung, Charles Catton, Andrew Bayley, Michael Milosevic, Robert Bristow, Padraig Warde, Anna Simeonov, David A. Jaffray, Masoom A. Haider, Cynthia Ménard

Research output: Contribution to journalArticlepeer-review


Purpose: To evaluate regional and temporal changes in apparent diffusion coefficient (ADC) and T2 relaxation during radiation therapy (RT) in patients with low and intermediate risk localized prostate cancer. Materials and Methods: Seventeen patients enrolled on a prospective clinical trial where MRI was acquired every 2 weeks throughout eight weeks of image-guided prostate IMRT (78 Gy/39 fractions). ADC and T2 quantification used entire prostate, central gland, benign peripheral zone, and tumor-dense regions-of-interest, and mean values were evaluated for common response trends. Results: Overall, the RT responses were greater than volunteer measurement repeatability, and week 6 appeared to be an optimum time-point for early detection. RT effects on the entire prostate were best detected using ADC (5-7% by week 2, P < 0.0125), effects on peripheral zone were best detected using T2 (19% reduction at week 6; P = 0.004) and effects on tumors were best detected using ADC (14% elevation at week 6; P = 0.004). Conclusion: ADC and T2 may be candidate biomarkers of early response to RT warranting further investigation against clinical outcomes.

Original languageEnglish
Pages (from-to)909-916
Number of pages8
JournalJournal of Magnetic Resonance Imaging
Issue number4
Publication statusPublished - 23 Oct 2012


  • ADC
  • prostate cancer
  • radiation therapy
  • T
  • treatment response

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre


Dive into the research topics of 'Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer'. Together they form a unique fingerprint.

Cite this